John G. Matthews

Lebrikizumab Treatment in Adults with Asthma

Jonathan Corren, Robert F. Lemanske, Nicola A. Hanania et al. · New England Journal of Medicine · 2011 · 1.5K citations

A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma

Patrick Flood-Page, Cheri A. Swenson, Isidore Faiferman et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 737 citations

Effects of Treatment with Anti-immunoglobulin E Antibody Omalizumab on Airway Inflammation in Allergic Asthma

Ratko Djukanović, Susan J. Wilson, Monica Kraft et al. · American Journal of Respiratory and Critical Care Medicine · 2004 · 646 citations

Asthma, Inflammatory Lung Disease, Lung Inflammation +16

Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort

Dominick Shaw, Ana R. Sousa, Stephen J. Fowler et al. · European Respiratory Journal · 2015 · 548 citations · Full text

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

Nicola A. Hanania, Phillip E. Korenblat, Kenneth R. Chapman et al. · The Lancet Respiratory Medicine · 2016 · 463 citations

Asthma, Rheumatology, Allergy +10